Endocrinology, Diabetes & Metabolism Case Reports (Aug 2018)
Beat the giant: case of a giant prolactinoma during pregnancy on cabergoline
Abstract
Giant prolactinomas are a rare entity; during pregnancy, the risk for complications associated with these tumors is higher. Here, we report a case of a young woman who had an invasive, giant prolactinoma post resection with residual disease who became pregnant. This patient was treated with cabergoline to prevent tumor expansion in pregnancy, resulting in the uneventful delivery of a healthy baby boy.